David Wiley

David Wiley, PhD, currently serves as Associate Director at Life Edit Therapeutics since October 2022. Prior to this role, David was a Senior Scientist at Prime Medicine, Inc., where significant advancements in pooled screening platforms were achieved, leading to numerous patents. David's experience includes being a Research Scientist II at Vertex Pharmaceuticals, focusing on flow cytometry-based assays and CRISPR pool screens, and receiving multiple accolades for collaborative achievements. David's early career involved a Postdoctoral Fellowship at Boston Children's Hospital/Harvard Medical School, where crucial insights into the Thyroid hormone pathway and globin switching were developed under the mentorship of Dr. Leonard Zon. David holds a PhD in Cell, Molecular, and Developmental Biology from the University of North Carolina at Chapel Hill and was awarded a Bachelor of Science in Genetics and Cell Biology from The University of Georgia.